Purchases and Sales Made in Q3 2021 in Cyclacel Pharmaceuticals, Inc. (CYCC)
This table provides information about the institutional ownership of Cyclacel Pharmaceuticals, Inc. (CYCC) during Q3 2021. The information is specifically focused on institutions that hold shares of Cyclacel Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 15, 2021
Q3 2021
|
Tri Locum Partners LP
New York, NY |
BUY
|
- |
210K+ 66.9% |
$1.68M - $2.31M
|
523K
$329K
|
|
|
Nov 15, 2021
Q3 2021
|
Silverarc Capital Management, LLC
|
BUY
|
- |
131K+ 50.66% |
$1.05M - $1.44M
|
389K
$245K
|
|
|
Nov 15, 2021
Q3 2021
|
Morgan Stanley
New York, NY |
BUY
|
- |
112KNew |
$900K - $1.23M
|
112K
$70.7K
|
|
|
Nov 15, 2021
Q3 2021
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
BUY
|
- |
110K+ 929.66% |
$880K - $1.21M
|
122K
$76.5K
|
|
|
Nov 12, 2021
Q3 2021
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
20KNew |
$161K - $220K
|
20K
$12.6K
|
|
|
Nov 12, 2021
Q3 2021
|
Affinity Asset Advisors, LLC
New York, NY |
BUY
|
- |
20K+ 5.26% |
$160K - $220K
|
400K
$252K
|
|
|
Nov 12, 2021
Q3 2021
|
Dimensional Fund Advisors LP
Austin, TX |
BUY
|
- |
14KNew |
$112K - $154K
|
14K
$8.8K
|
|
|
Nov 15, 2021
Q3 2021
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
13.3KNew |
$107K - $147K
|
13.3K
$8.4K
|
|
|
Nov 15, 2021
Q3 2021
|
State Street Corp
Boston, MA |
BUY
|
- |
10.5KNew |
$84.3K - $116K
|
10.5K
$6.62K
|
|
|
Nov 12, 2021
Q3 2021
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
8.07K+ 15.87% |
$64.8K - $88.8K
|
58.9K
$37.1K
|
|
|
Nov 15, 2021
Q3 2021
|
Sio Capital Management, LLC
New York, NY |
BUY
|
- |
5.73K+ 1.37% |
$45.9K - $63K
|
423K
$266K
|
|
|
Nov 16, 2021
Q3 2021
|
Schonfeld Strategic Advisors LLC
New York, NY |
BUY
|
- |
1.4K+ 1.37% |
$11.2K - $15.4K
|
104K
$65.5K
|
|
|
Nov 15, 2021
Q3 2021
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
1.34KNew |
$10.7K - $14.7K
|
1.34K
$844
|
|
|
Nov 09, 2021
Q3 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-2- 0.36% |
$16 - $22
|
553
$348
|
|
|
Nov 15, 2021
Q3 2021
|
Ubs Group Ag
|
SELL
|
- |
-72Closed |
$577 - $792
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-233Closed |
$1.87K - $2.56K
|
0
$0
|
|
|
Nov 09, 2021
Q3 2021
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-548- 2.08% |
$4.39K - $6.03K
|
25.8K
$16.3K
|
|
|
Nov 15, 2021
Q3 2021
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-578- 0.58% |
$4.64K - $6.36K
|
99.4K
$62.6K
|
|
|
Nov 12, 2021
Q3 2021
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-6.5KClosed |
$52.1K - $71.5K
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-10.5KClosed |
$84.6K - $116K
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-16.8K- 35.8% |
$135K - $185K
|
30.2K
$19K
|
|
|
Nov 02, 2021
Q3 2021
|
Raymond James Financial Services Advisors, Inc.
St. Petersburg, FL |
SELL
|
- |
-50K- 83.33% |
$401K - $550K
|
10K
$6.3K
|
|
|
Nov 15, 2021
Q3 2021
|
Pura Vida Investments, LLC
New York, NY |
SELL
|
- |
-52.2K- 33.17% |
$419K - $574K
|
105K
$66.2K
|
|
|
Nov 15, 2021
Q3 2021
|
Maven Securities LTD
St Helier, Y9 |
SELL
|
- |
-211K- 90.01% |
$1.69M - $2.32M
|
23.4K
$14.8K
|
|
|
Nov 15, 2021
Q3 2021
|
J. Goldman & CO LP
New York, NY |
SELL
|
- |
-442KClosed |
$3.55M - $4.87M
|
0
$0
|